Dr. Mohan Cooray believes the naturally occurring immunomodulatory properties that plant cannabinoids possess absolutely require expedited investigation.

Just how will the coronavirus epidemic end? It’s a question you’ve probably wondered about multiple times during this period of quarantine and social distancing. If not, you likely wish things would just go back to normal. According to experts, one way the outbreak could end is doctors developing medications that prevent and/or treat the infection.

One medical supplier recently asked Health Canada for approval to study the effects of cannabis on COVID-19 patients. Dr. Mohan Cooray, who serves as president and CEO of Cannalogue, an online medical cannabis retailer in Toronto, wants to examine if certain cannabinoids can reduce inflammation and potential boost immune systems in a formal, rigorous setting.

“What we know from medical cannabis over the course of the literature and the experience we’ve had in Canada over the years is that there are known anti-inflammatory properties that cannabinoids have—cannabinoids being the active ingredients that come from the cannabis plant,” Dr. Cooray told The Toronto Sun.

However, with all research there will be scrutiny, reason number one anti-inflammation medication isn’t good for covid19. We can only hope some of the many chemical components in the plant can prove useful I guess we are just going to have to wait for this lab research to be concluded. In the meantime let’s just relieve the PTSD that we are collectively suffering from every time someone coughs.